A. Lamb

Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of cancer
20231 citationsauthor #15
Clinical performance of magnetic resonance imaging and biomarkers for prostate cancer diagnosis in men at high genetic risk
20237 citationsauthor #9
Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial
20230 citationsauthor #3
The Detection of Prostate Cancer With Magnetic Resonance Imaging-targeted Prostate Biopsies Is Superior With the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. Letter.
20230 citationsauthor #3
Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types
20231 citationsauthor #6
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of heterogeneity on genomic signature scoring
20230 citationsauthor #21
Abstract A051: The spatial landscape of clonal somatic copy number alterations in benign and malignant prostate epithelia
20230 citationsauthor #30
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?
20236 citationsauthor #5
Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features
20237 citationsauthor #18
Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia
20235 citationsauthor #8
Re: Fifteen-year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
20232 citationsauthor #5
MP45-14 THE SPATIAL LANDSCAPE OF CLONAL SOMATIC MUTATIONS IN BENIGN AND MALIGNANT PROSTATE EPITHELIA
20220 citationsauthor #28
The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters
202212 citationsauthor #7
Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?
20221 citationsauthor #5
Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones
202214 citationsauthor #11
MP51-13 FLUORINE-18 (18F) PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITRON EMISSION TOMOGRAPHY (PET) AND THE DIAGNOSIS AND STAGING OF PRIMARY PROSTATE CANCER (PCA)
20220 citationsauthor #22
Re: Prostate Cancer Screening Using a Combination of Risk-prediction, MRI, and Targeted Prostate Biopsies (STHLM3-MRI): A Prospective, Population-based, Randomised, Open-label, Non-inferiority Trial.
20220 citationsauthor #3
Abstract PR016: The spatial landscape of clonal somatic mutations in benign and malignant tissue
20228 citationsauthor #28
Spatially resolved clonal copy number alterations in benign and malignant tissue
2022227 citationsauthor #30
PD03-12 COVID-19 DISRUPTION TO PROSTATE CANCER MANAGEMENT IN A UK TERTIARY REFERRAL CENTRE
20220 citationsauthor #21
The provision of prostate cancer patient information leaflets on an electronic tablet: A further step to paperless health-care provision
20221 citationsauthor #6
Abstract 401: Single-cell transcriptome and chromatin sequencing uncover gene expression and gene regulatory patterns associated with enzalutamide resistance
20220 citationsauthor #27
Genomic sequencing in oncology: Considerations for integration in routine cancer care
20228 citationsauthor #2
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer
202110 citationsauthor #21
Zinc stable isotopes in urine as diagnostic for cancer of secretory organs.
202120 citationsauthor #10
Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.
202118 citationsauthor #15
Protocol for 18 F-PSMA PET imaging in staging and management of prostate 1 cancer – a retrospective cohort study 2
20210 citationsauthor #16
Risks and Benefits of Live Surgical Broadcast: A Systematic Review.
20217 citationsauthor #9
Ductal adenocarcinoma of the prostate: A systematic review and meta‐analysis of incidence, presentation, prognosis, and management
202130 citationsauthor #18
Use of intraoperative fluorescence to enhance robot-assisted radical prostatectomy.
20215 citationsauthor #10
A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease.
202130 citationsauthor #10
Protocol for 18F-PSMA PET imaging in staging and management of prostate cancer - a retrospective cohort study
20211 citationsauthor #15
Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate Cancer
202126 citationsauthor #9
Corrigendum to "Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score" [Eur Urol Focus 6 (2020) 458-62].
20201 citationsauthor #8
Harnessing the potential of multimodal radiotherapy in prostate cancer
202020 citationsauthor #3
Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.
2020271 citationsauthor #19
MP67-19 DUCTAL ADENOCARCINOMA OF THE PROSTATE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INCIDENCE, PRESENTATION AND MANAGEMENT
20200 citationsauthor #16
PO-1160: A pilot dual-platform transcriptomic analysis of diagnostic prostate biopsies & radical RT response
20200 citationsauthor #5
A lesion specific analysis of the performance of multiparametric MRI in detection of clinically significant prostate cancer in the PART feasibility trial
20200 citationsauthor #14
Surgery for disorders of erectile function, ejaculation, and seminal vesicles
20200 citationsauthor #3
Exploi'ng the synergy of mul'modal radiotherapy in prostate cancer
20200 citationsauthor #3
Medicolegal aspects of urology
20200 citationsauthor #3
Surgery for upper tract obstruction and other ureteric surgery
20200 citationsauthor #3
Ductal adenocarcinoma portends a significantly shorter metastasis-free survival
20200 citationsauthor #14
V14-08 ANTERIOR RETZIUS SPARING: STEP-BY-STEP
20200 citationsauthor #1
Harnessing the power of RNA in determining the origin of lethal micro-metastatic prostate cancer
20200 citationsauthor #10
Basic urological surgical skills and equipment
20200 citationsauthor #3
Management of the neuropathic bladder
20200 citationsauthor #3
Investigating tumour immune microenvironment effects of hypofractionated radiotherapy +/- immune checkpoint blockade in immunocompetent pre-clinical prostate cancer models
20200 citationsauthor #7
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
20202 citationsauthor #10
Scrotal and penile surgery
20200 citationsauthor #3
Anterior prostatectomy for the excision of bladder paraganglioma with prostatic invasion: a unique case of partial prostatectomy
20202 citationsauthor #2
Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit – the ‘Fry‐Turnbull’ effect
20209 citationsauthor #13
Trauma to the genitourinary tract and other urological emergencies
20200 citationsauthor #3
General principles of urological surgery
20200 citationsauthor #3
Negative predictive value of multi-parametric MRI in detection of clinically significant prostate cancer in the PI-RADS era: a systematic review and meta-analysis
20200 citationsauthor #21
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
202064 citationsauthor #10
MP64-09 DUCTAL ADENOCARCINOMA OF THE PROSTATE IS ASSOCIATED WITH SHORTER METASTASIS-FREE SURVIVAL
20200 citationsauthor #15
“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now
2020102 citationsauthor #5
Surgery for male factor infertility
20200 citationsauthor #3
Surgery for urological cancer
20200 citationsauthor #3
Editorial Comment.
20200 citationsauthor #3
Laparoscopic and robotic urological surgery
20200 citationsauthor #3
Tumor irradiation combined with vascular-targeted photodynamic therapy enhances anti-tumor effects in preclinical prostate cancer
20200 citationsauthor #21
Bladder outlet obstruction and transurethral surgery
20200 citationsauthor #3
Female urology and incontinence surgery
20200 citationsauthor #3
A pilot transcriptomic analysis of archival prostate biopsy samples and response to radical radiotherapy
20200 citationsauthor #5
Detailed molecular and immune marker profiling of archival prostate cancer samples reveals an inverse association between TMPRSS2:ERG fusion status and immune cell infiltration.
202010 citationsauthor #11
Social Media Coverage of Scientific Articles Immediately After Publication Predicts Subsequent Citations - #SoME_Impact Score: Observational Analysis
202025 citationsauthor #6
Uroradiological and other interventions
20200 citationsauthor #3
TRoMbone: Testing radical prostatectomy in men with oligo metastatic prostate cancer that has spread to the bone - a randomized controlled feasibility trial
20193 citationsauthor #8
Prostatic capsular incision during radical prostatectomy has important oncological implications: a systematic review and meta‐analysis
201910 citationsauthor #10
Negative predictive value of multi-parametric MRI in detection of clinically significant prostate cancer: A systematic review and meta-analysis
20192 citationsauthor #14
MP24-16 LOCAL ANAESTHETIC TRANSPERINEAL PROSTATE (LATP) BIOPSY USING THE PRECISION POINT ACCESS SYSTEM: A MULTI-CENTRE OUTCOME ANALYSIS
20195 citationsauthor #15
PD15-09 TROMBONE: TESTING RADICAL PROSTATECTOMY IN MEN WITH OLIGOMETASTATIC PROSTATE CANCER THAT HAS SPREAD TO THE BONE- A RANDOMIZED CONTROLLED FEASIBILITY TRIAL
20193 citationsauthor #8
Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score.
201919 citationsauthor #7
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression.
2019133 citationsauthor #14
Local anaesthetic transperineal prostate (LATP) biopsy using the precision point access system: A step-by-step video
20192 citationsauthor #4
Genetic Reasons to Walk the Extra Mile to Prevent Prostate Cancer.
20190 citationsauthor #2
MP24-19 NEGATIVE PREDICTIVE VALUE OF MULTI-PARAMETRIC MRI IN DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
20190 citationsauthor #16
Social media coverage of scientific articles immediately after publication predicts subsequent citations: #SoMe_Impact Score
20190 citationsauthor #6
Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer: a Cochrane Review
201911 citationsauthor #6
Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
201933 citationsauthor #12
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
2018124 citationsauthor #23
Selected abstracts from SURG 2016
20180 citationsauthor #15
First Report of Prostate-specific Membrane Antigen-targeted Immunotherapy in Prostate Cancer: The Future is Bright.
20187 citationsauthor #1
Social Media Coverage of Scientific Articles Immediately After Publication Predicts Subsequent Citations - #SoME_Impact Score: Observational Analysis (Preprint)
20180 citationsauthor #6
Changing face of robot‐assisted radical prostatectomy in Melbourne over 12 years
20189 citationsauthor #2
Identification of potential therapeutic targets in prostate cancer through a cross‐species approach
201837 citationsauthor #6
Pathologist Assessment of Novel Histological Features in Prostate Cancer
20180 citationsauthor #4
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
2018124 citationsauthor #24
Living and learning in Melbourne
20170 citationsauthor #1
DESNT: A Poor Prognosis Category of Human Prostate Cancer.
201738 citationsauthor #14
An evaluation of a selective prostate cancer screening program using family history as a supplementary screening tool to PSA: Results from the ProtecT trial
20172 citationsauthor #2
Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer.
201735 citationsauthor #6
Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective
20177 citationsauthor #6
Systematic Review of Studies Reporting Positive Surgical Margins After Bladder Neck Sparing Radical Prostatectomy
201739 citationsauthor #6
Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015) 1133–1144]
20173 citationsauthor #2
Salvage robotic prostatectomy for radio recurrent prostate cancer: technical challenges and outcome analysis.
201742 citationsauthor #2
Re: Diagnostic Accuracy of Multi-parametric MRI and TRUS Biopsy in Prostate Cancer (PROMIS): A Paired Validating Confirmatory Study.
20176 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT